-
EP2292258
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2292258
| EP2292258 - Multiepitope vaccine for Her2/neu-associated cancers [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.02.2012 Database last updated on 30.10.2024 | Most recent event Tooltip | 03.02.2012 | Application deemed to be withdrawn | published on 07.03.2012 [2012/10] | Applicant(s) | For all designated states Pevion Biotech Ltd. Worblentalstrasse 32 3063 Ittigen / CH | [2011/10] | Inventor(s) | 01 /
Kammer, Andreas, Dr. Häberlimatte Weg 14 3052 Zollikofen / CH | 02 /
Amacker, Mario, Dr. Wünnewilstrasse 11B 3185 Schmitten / CH | 03 /
Zurbriggen, Rinaldo, Dr. Rainstrasse 40 3185 Schmitten / CH | [2011/10] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [2011/10] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE | Application number, filing date | 09010627.9 | 18.08.2009 | [2011/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2292258 | Date: | 09.03.2011 | Language: | EN | [2011/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.12.2009 | Classification | IPC: | A61K39/00 | [2011/10] | CPC: |
C07K14/71 (EP,US);
A61K39/001106 (EP,US);
A61P35/00 (EP);
A61P37/04 (EP);
A61K2039/55555 (EP,US);
A61K2039/55577 (EP,US);
A61K2039/6037 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/10] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | Multiepitop-Impfstoff für Her2/neu-assoziierten Krebs | [2011/10] | English: | Multiepitope vaccine for Her2/neu-associated cancers | [2011/10] | French: | Vaccin multi-épitope pour les cancers associés à Her2/Neu | [2011/10] | Examination procedure | 18.08.2009 | Examination requested [2011/10] | 19.09.2011 | Application deemed to be withdrawn, date of legal effect [2012/10] | 18.10.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/10] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.08.2011 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP1236740 (BIO LIFE SCIENCE FORSCHUNGS & ENTWICKLUNGSGESELLSCHAFT MBH [AT]); | [Y]CN1749276 (DIWEI HUAYU BIOLOG TECHNOLOGY [CN]); | [X]US7060284 (KAUMAYA PRAVIN T P [US]); | [Y]EP1844788 (BIO LIFE SCIENCE FORSCHUNGS & ENTWICKLUNGSGESELLSCHAFT MBH [AT]); | by applicant | EP1236740 | WO02068474 | WO2007118660 | EP1884788 |